Valbiotis Stock
Price
Target price
€1.30
€1.30
-0.610%
-0.008
-0.610%
-
18.09.24 / Frankfurt
WKN: A2DS5F / Name: Valbiotis / Stock / Biotechnology & Medical Research / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Valbiotis Stock
Valbiotis shows a slight decrease today, losing -€0.008 (-0.610%) compared to yesterday.
So far the community has only identified positive things for Valbiotis stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Valbiotis in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Valbiotis vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Valbiotis | -0.610% | - | - | - | - | - | - |
Cerenis Therapeutics Holding S.A. | 0.690% | -7.120% | -10.518% | 4.263% | -4.708% | 25.696% | 310.490% |
Sensorion SA | -2.430% | 8.600% | 35.583% | 34.962% | 121.000% | -57.295% | - |
Genoway S.A. Inh. | -0.280% | -3.794% | -7.552% | 0.000% | -19.501% | -14.251% | 150.000% |
News
VALBIOTIS : Oral presentation at the 2024 EASD congress
VALBIOTIS : Oral presentation at the 2024 EASD congress
Valbiotis invited to present clinical results at the American Diabetes Association’s 84th Scientific Sessions
Valbiotis invited to present clinical results at the American Diabetes Association’s 84th Scientific Sessions
Valbiotis reaches an agreement to terminate its licensing and supply agreement with Nestlé Health Science
Valbiotis reaches an agreement to terminate its licensing and supply agreement with Nestlé Health Science